Henderin, Cherry Ann .
HRN: 25-94-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/27/2024
09/28/2024
IV
500 Mg
Q8
T/c Endometritis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes